Dorostkar, H.; Haghiralsadat, B.F.; Hemati, M.; Safari, F.; Hassanpour, A.; Naghib, S.M.; Roozbahani, M.H.; Mozafari, M.R.; Moradi, A.
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies. Pharmaceutics 2023, 15, 1920.
https://doi.org/10.3390/pharmaceutics15071920
AMA Style
Dorostkar H, Haghiralsadat BF, Hemati M, Safari F, Hassanpour A, Naghib SM, Roozbahani MH, Mozafari MR, Moradi A.
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies. Pharmaceutics. 2023; 15(7):1920.
https://doi.org/10.3390/pharmaceutics15071920
Chicago/Turabian Style
Dorostkar, Hamidreza, Bibi Fatemeh Haghiralsadat, Mahdie Hemati, Fatemeh Safari, Azam Hassanpour, Seyed Morteza Naghib, Mohammad Hossein Roozbahani, M. R. Mozafari, and Ali Moradi.
2023. "Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies" Pharmaceutics 15, no. 7: 1920.
https://doi.org/10.3390/pharmaceutics15071920
APA Style
Dorostkar, H., Haghiralsadat, B. F., Hemati, M., Safari, F., Hassanpour, A., Naghib, S. M., Roozbahani, M. H., Mozafari, M. R., & Moradi, A.
(2023). Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies. Pharmaceutics, 15(7), 1920.
https://doi.org/10.3390/pharmaceutics15071920
